NYSE$CC

The Chemours · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Chemours reported strong first-quarter results, driven by exceptional performance in TSS and APM segments and increased full-year Adjusted EBITDA guidance by 12%.

Chemours reported a strong first quarter with net sales of $1.8 billion, up 23% year-over-year. The company's TSS and APM segments delivered exceptional results, reflecting strong pricing and demand. As a result, Chemours raised its full-year Adjusted EBITDA guidance by 12% at the midpoint.

  • Net Sales increased by 23% year-over-year, reaching $1.8 billion.
  • Net Income was $234 million, with an EPS of $1.43, an increase of $0.86 year-over-year.
  • Adjusted EBITDA increased by 50% year-over-year, reaching $403 million.
  • The company raised its full-year Adjusted EBITDA guidance to between $1.475 billion and $1.575 billion.

Headline financials

Total Revenue

$1.76B

Previous: $1.44B+22.8%
EPS (adj)

$1.46

Previous: $0.71+105.6%
Capital Expenditures

-$106M

Previous: -$60M-76.7%
Free Cash Flow

$128M

Previous: $36M+255.6%
Net Income

$234M

Previous: $96M+143.8%
Operating Income

$304M

Previous: $139M+118.7%
Gross Profit

$486M

Previous: $297M+63.6%
Cash & Equivalents

$1.15B

Previous: $1.01B+13.6%
Total Assets

$7.52B

Previous: $7.17B+4.9%
Stock-Based Comp

$10M

Previous: $12M-16.7%

Revenue & EPS history

Chemours · Revenue · Quarterly

$1.76B

Q1 2022+22.8%vs Q1 2021
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Forward guidance

Chemours now expects full year Adjusted EBITDA to be between $1.475 billion and $1.575 billion, and Free Cash Flow is expected to be greater than $550 million.

Tailwinds

  • Full year Adjusted EBITDA is now expected to be between $1.475 billion and $1.575 billion vs. prior guidance of between $1.3 billion and $1.425 billion.
  • Free Cash Flow is expected to be greater than $550 million vs. prior guidance of greater than $500 million.
  • Secular strength in TSS
  • Secular strength in APM
  • Strong customer demand

Headwinds

  • Ore constraints in TT will continue in the second half of the year.
  • Persistent supply chain challenges
  • Global economic uncertainties
  • Conflict in Ukraine
  • Ongoing COVID-19 related lockdowns in China

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+1.4%

Avg return

Earnings day

+2.4%

Avg return

5 days after

+1.2%

Avg return

30 days after

55%

27 / 49 earnings

Positive

+24.2%

Q4 2019

Best reaction

-23.0%

Q2 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-15.7%-9.6%-26.8%
Q4 2025-16.5%-11.7%-13.3%
Q3 2025+6.8%+7.4%+8.2%
Q1 2025-9.4%-0.9%-8.1%
Q4 2024+3.9%-0.4%-12.8%
Q3 2024+11.6%+11.1%+19.4%
Q2 2024-15.0%-22.5%-19.6%
Q1 2024-6.1%-4.0%-7.6%
Q4 2023-4.1%+5.0%-0.2%
Q3 2023-0.1%+2.1%+11.7%
Q2 2023-4.8%-4.0%-14.8%
Q1 2023+6.4%+11.1%+4.4%
Q4 2022-1.7%-0.8%-10.7%
Q3 2022+1.0%-0.9%+13.5%
Q2 2022+4.0%+1.6%+4.5%
Q1 2022+17.7%+21.1%+31.7%
Q4 2021-16.8%-13.9%-26.9%
Q3 2021+8.0%+4.7%-3.0%
Q2 2021+1.9%+4.7%+6.5%
Q1 2021+4.4%+14.7%+23.0%
Q4 2020-2.6%-1.8%+7.1%
Q3 2020+2.2%+8.3%+23.0%
Q2 2020-0.3%+5.9%+12.8%
Q1 2020+12.9%+18.3%+44.4%
Q4 2019+24.2%+19.1%-33.9%
Q3 2019+13.9%+13.4%-11.1%
Q2 2019-23.0%-26.5%-25.7%
Q1 2019-1.8%-16.4%-39.4%
Q4 2018-2.6%-3.0%-2.2%
Q3 2018+4.1%+2.9%-13.7%
Q2 2018+4.9%+6.7%-2.8%
Q1 2018+4.5%+4.4%+1.7%
Q4 2017+2.7%+2.5%+4.5%
Q3 2017-8.4%-10.5%-9.0%
Q2 2017-1.6%+3.8%+4.3%
Q1 2017-1.0%+2.4%-0.7%
Q4 2016-0.5%+3.1%+8.4%
Q3 2016+12.7%+21.1%+52.3%
Q2 2016+13.2%+25.8%+49.6%
Q1 2015-3.1%
Q1 2016+9.6%
Q1 2014+2.3%
Q4 2013+2.3%
Q4 2015+14.3%
Q3 2014-17.2%
Q3 2015-17.2%
Q4 2014+16.3%
Q2 2014+16.3%
Q2 2015+16.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro